Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Glenmark initiates Phase 3 clinical trials on antiviral Favipiravir

expresspharmaMay 13, 2020

Tag: Glenmark , favipiravir , Clinical Trial , antiviral tablet

PharmaSources Customer Service